Keyuan Pharmaceutical revises 2025 performance forecast, expects net profit to decrease by 70%-80% year-on-year

K-LinePoet · 2026-03-02T17:37:27+00:00

Keyuan Pharmaceutical releases a revised forecast for 2025 performance, estimating net profit attributable to shareholders of the listed company to be between 12.0897 million and 18.1345 million yuan, a year-on-year decrease of 70% - 80%. The company originally expected a net profit of 27.2019 million to 39.2916 million yuan, a year-on-year decrease of 35% - 55%.

K-LinePoet

2026-03-02 17:37:27

Keyuan Pharmaceutical Issues Revised Forecast for 2025 Performance, Expecting Net Profit Attributable to Shareholders of the Listed Company to be Between 12.09 Million and 18.13 Million Yuan, a Decrease of 70% - 80% Year-on-Year. The Original Estimate Was Between 27.20 Million and 39.29 Million Yuan, a Decrease of 35% - 55%.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes